You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-MAP2K2 (MAP2K2) Antibodies

Full name:
anti-Mitogen-Activated Protein Kinase Kinase 2 Antibodies (MAP2K2)
On www.antibodies-online.com are 249 Mitogen-Activated Protein Kinase Kinase 2 (MAP2K2) Antibodies from 29 different suppliers available. Additionally we are shipping MAP2K2 Proteins (18) and MAP2K2 Kits (10) and many more products for this protein. A total of 294 MAP2K2 products are currently listed.
Synonyms:
AA589381, ATMKK2, CFC4, F27B13.50, F27B13_50, MAP KINASE KINASE 1, MAP kinase kinase 2, MAPKK2, MEK2, MK1, MK2, MKK2, PRKMK2
list all antibodies Gene Name GeneID UniProt
MAP2K2 58960 P36506
MAP2K2 5605 P36507
MAP2K2 26396 Q63932

Show all species

Show all synonyms

Most Popular Reactivities for anti-MAP2K2 (MAP2K2) Antibodies

Select your species and application

anti-Rat (Rattus) MAP2K2 Antibodies:

anti-Human MAP2K2 Antibodies:

anti-Mouse (Murine) MAP2K2 Antibodies:

All available anti-MAP2K2 Antibodies

Go to our pre-filtered search.

Top referenced anti-MAP2K2 Antibodies

  1. Human Polyclonal MAP2K2 Primary Antibody for IHC (p), WB - ABIN1881526 : Burroughs, Oh, Barrett, DiAugustine et al.: Phosphatidylinositol 3-kinase and mek1/2 are necessary for insulin-like growth factor-I-induced vascular endothelial growth factor synthesis in prostate epithelial cells: a role for hypoxia-inducible ... in Molecular cancer research : MCR 2003 (PubMed)
    Show all 5 references for ABIN1881526

  2. Chicken Monoclonal MAP2K2 Primary Antibody for IHC (f), IF - ABIN967845 : Crews, Alessandrini, Erikson: The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product. in Science (New York, N.Y.) 1992 (PubMed)
    Show all 5 references for ABIN967845

  3. Human Polyclonal MAP2K2 Primary Antibody for IHC (p), WB - ABIN197106 : Alessi, Saito, Campbell, Cohen, Sithanandam, Rapp, Ashworth, Marshall, Cowley: Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1. in The EMBO journal 1994 (PubMed)
    Show all 2 references for ABIN197106

  4. Human Polyclonal MAP2K2 Primary Antibody for IHC, ELISA - ABIN1531905 : Rosen, Ginty, Weber, Greenberg: Membrane depolarization and calcium influx stimulate MEK and MAP kinase via activation of Ras. in Neuron 1994 (PubMed)
    Show all 2 references for ABIN1531905

  5. Human Polyclonal MAP2K2 Primary Antibody for EIA, IHC (p) - ABIN360373 : Tran, Maurer, Nagamine: Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinase-activated protein kinase 2. in Molecular and cellular biology 2003 (PubMed)
    Show all 2 references for ABIN360373

  6. Chicken Polyclonal MAP2K2 Primary Antibody for IHC, WB - ABIN2783573 : Adjei, Cohen, Franklin, Morris, Wilson, Molina, Hanson, Gore, Chow, Leong, Maloney, Gordon, Simmons, Marlow, Litwiler, Brown, Poch, Kane, Haney, Eckhardt: Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008 (PubMed)

More Antibodies against MAP2K2 Interaction Partners

Human Mitogen-Activated Protein Kinase Kinase 2 (MAP2K2) interaction partners

  1. at clinically relevant concentrations, cDDP binds to and inhibits MEK1 (show MAP2K1 Antibodies)/2 and both the binding and inhibitory activity are related to its interaction with Cu bound to MEK1 (show MAP2K1 Antibodies)/2

  2. Endocytosis separates EGF (show EGF Antibodies) receptors from endogenous fluorescently labeled HRas (show HRAS Antibodies) and diminishes receptor signaling to MAP kinases in endosomes.

  3. MEK1 (show MAP2K1 Antibodies) levels are upregulated at transcriptional level whereas MEK2 levels are downregulated at posttranslational level.

  4. MEK1/2 inhibitor trametinib showed similar PFS and a response rate as docetaxel in patients with previously treated KRAS-mutant-positive non-small cell lung carcinoma.

  5. We report on a fourth familial case with transmission of CFC (show PTPN11 Antibodies) syndrome from father to son due to a novel heterozygous sequence change c.376A>G (p.N126D) in exon 3 of MEK2 gene.

  6. MK2 (show KCNA2 Antibodies) attenuates dendritic cell-mediated Th1 (show TH1L Antibodies) differentiation and autoimmune encephalomyelitis.

  7. We documented three novel mutations in the BRAF (show BRAF Antibodies) gene in cardio-facio-cutaneous syndrome patients and correlated clinical findings with causative mutations in the BRAF (show BRAF Antibodies) or MEK1 (show MAP2K1 Antibodies)/MEK2 genes

  8. CCR7 (show CCR7 Antibodies) can also promote survival of mDCs through a novel MEK1 (show MAP2K1 Antibodies)/2-ERK1/2 (show MAPK1/3 Antibodies)-AMPK (show PRKAA1 Antibodies) signaling axis.

  9. Our cohort of seven individuals with MEK2 deletions has overlapping features associated with RASopathies.

  10. Both ACE (show ACE Antibodies) inhibition and MEK1 (show MAP2K1 Antibodies)/2 inhibition have beneficial effects on left ventricular function in Lmna (show LMNA Antibodies)(H222P/H222P) mice and both drugs together have a synergistic benefit when initiated after the onset of left ventricular dysfunction.

Mouse (Murine) Mitogen-Activated Protein Kinase Kinase 2 (MAP2K2) interaction partners

  1. MEK1 (show MAP2K1 Antibodies) and MEK2 can substitute for each other but a minimum amount of MEK (show MDK Antibodies) is critical for placenta development and embryo survival

  2. MK2 (show KCNA2 Antibodies)/3 cascade plays a strategic role in controlling synaptic plasticity and cognition.

  3. MK2 (show KCNA2 Antibodies) attenuates dendritic cell-mediated Th1 (show HAND1 Antibodies) differentiation and autoimmune encephalomyelitis.

  4. analysis of p38 (show CRK Antibodies)-MK2 (show KCNA2 Antibodies)-activated Rsk (show RPS6KA1 Antibodies) signaling in toll (show TLR4 Antibodies)-like receptor-stimulated dendritic cells

  5. both MEK1 (show MAP2K1 Antibodies) and MEK2 have crucial roles in the integration of mesenchymal and epithelial signals essential for the development of the entire respiratory tract

  6. MK2 (show KCNA2 Antibodies) is responsible for resistance of p53 (show TP53 Antibodies)-deficient tumors to cisplatin

  7. MK2 (show KCNA2 Antibodies) plays a critical role in the development of apoptosis.

  8. rapamycin treatment led to an increased MKP1 (show DUSP1 Antibodies) expression in BMDM from WT but failed to do so in BMDMs lacking the AKT1 (show AKT1 Antibodies) isoform or MEK1 (show MAP2K1 Antibodies) and MEK2.

  9. review focuses on the role of the MEK1 (show MAP2K1 Antibodies) and MEK2 kinases in the development of extraembryonic tissues and in the formation of the placenta

  10. AT(2)R-mediated eNOS (show NOS3 Antibodies) NO production and vasorelaxation through a MEK (show MDK Antibodies) pathway are enhanced in aortas from db/db (show LEPR Antibodies) mice.

Arabidopsis thaliana Mitogen-Activated Protein Kinase Kinase 2 (MAP2K2) interaction partners

  1. the AtMKK2-AtMPK10 (show MAPK10 Antibodies) MAPK (show MAPK1 Antibodies) module regulates leaf venation complexity by altering polar auxin transport efficiency

  2. Treatment of Arabidopsis with a membrane rigidifier, DMSO, causes MPK4 (show MAPK4 Antibodies) activation concomitantly with MEKK1 (show MAP3K1 Antibodies) and MKK2 phosphorylation.

  3. Ca(2 (show CA2 Antibodies)+) signaling occurred upstream of the MEKK1 (show MAP3K1 Antibodies)-MKK2 pathway. MEKK1 (show MAP3K1 Antibodies) was phosphorylated by calcium/calmodulin (show CALM Antibodies)-regulated receptor-like kinase (CRLK1), which suggested that CRLK1 is one of candidates located upstream of MEKK1 (show MAP3K1 Antibodies).

  4. Data indicate that MEKK2 (show MAP3K2 Antibodies) is required for the mekk1 (show MAP3K1 Antibodies), mkk1 (show MAP2K1 Antibodies) mkk2, and mpk4 (show MAPK4 Antibodies) autoimmune phenotypes.

  5. Data suggest that the MEKK1 (show MAP3K1 Antibodies)-MKK1 (show MAP2K1 Antibodies)/MKK2-MPK4 (show MAPK4 Antibodies) kinase cascade negatively regulates MEKK2 (show MAP3K2 Antibodies) and activation of MEKK2 (show MAP3K2 Antibodies) triggers SUMM2-mediated immune responses.

  6. Data indicate that MKK2 plays a role in abiotic stress tolerance and plant disease resistance.

  7. double loss-of-function mutant (mkk1 (show MAP2K1 Antibodies)/2) of MKK1 (show MAP2K1 Antibodies) and MKK2 is shown to have marked phenotypes in development and disease

  8. Activation of MPK4 (show MAPK4 Antibodies) by flg22 is impaired in the mkk1 (show MAP2K1 Antibodies) mkk2 double mutants, suggesting that MKK1 (show MAP2K1 Antibodies) and MKK2 function together with MPK4 (show MAPK4 Antibodies) and MEKK1 (show MAP3K1 Antibodies) in a MAP kinase (show MAPK1 Antibodies) cascade to negatively regulate innate immune responses in plants.

MAP2K2 Antigen Profile

Antigen Summary

The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is known to play a critical role in mitogen growth factor signal transduction. It phosphorylates and thus activates MAPK1/ERK2 and MAPK2/ERK3. The activation of this kinase itself is dependent on the Ser/Thr phosphorylation by MAP kinase kinase kinases. Mutations in this gene cause cardiofaciocutaneous syndrome (CFC syndrome), a disease characterized by heart defects, mental retardation, and distinctive facial features similar to those found in Noonan syndrome. The inhibition or degradation of this kinase is also found to be involved in the pathogenesis of Yersinia and anthrax. A pseudogene, which is located on chromosome 7, has been identified for this gene.

Alternative names and synonyms associated with MAP2K2

  • mitogen activated protein kinase kinase 2 (Map2k2) antibody
  • mitogen-activated protein kinase kinase 2 (MAP2K2) antibody
  • mitogen-activated protein kinase kinase 2 (Map2k2) antibody
  • mitogen-activated protein kinase kinase 2 (MKK2) antibody
  • AA589381 antibody
  • ATMKK2 antibody
  • CFC4 antibody
  • F27B13.50 antibody
  • F27B13_50 antibody
  • MAP KINASE KINASE 1 antibody
  • MAP kinase kinase 2 antibody
  • MAPKK2 antibody
  • MEK2 antibody
  • MK1 antibody
  • MK2 antibody
  • MKK2 antibody
  • PRKMK2 antibody

Protein level used designations for MAP2K2

ERK activator kinase 2 , MAP kinase kinase 2 , MAPK/ERK kinase 2 , MAPKK 2 , MEK 2 , MEK2 , dual specificity mitogen-activated protein kinase kinase 2 , mitogen-activated protein kinase kinase 2, p45 , MAP kinase/Erk kinase , mitogen activated protein kinase kinase 2 , protein kinase, mitogen activated, kinase 2, p45 , dual specificity mitogen activated protein kinase kinase 2 , mitogen-activated protein kinase kinase type 2

GENE ID SPECIES
58960 Rattus norvegicus
5605 Homo sapiens
26396 Mus musculus
611939 Canis lupus familiaris
396349 Gallus gallus
510434 Bos taurus
829103 Arabidopsis thaliana
Selected quality suppliers for anti-MAP2K2 (MAP2K2) Antibodies
Did you look for something else?